Quarterly report · Q2
7090.TEDINET S100PJLS
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥3.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | −¥356m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥98m | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | −¥365m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥151m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥92m | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥365m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥60m | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥266m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥72m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥32m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥266m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥32m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥3.9bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.1bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥857m | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥182m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥80m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥8m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥552m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥475m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥190m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥766m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥154m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥209m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-188.99 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-85.09 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥51.64 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.12 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥11.61 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.55 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.53 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 21.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.7% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E33790-000Financial Services Segmentsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥389m |
| jpcrp040300-q2r_E33790-000Financial Services Segmentsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥389m |
| jpcrp040300-q2r_E33790-000Financial Services Segmentsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥23m |
| jpcrp040300-q2r_E33790-000Osteopathic Solution Segmentsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥848m |
| jpcrp040300-q2r_E33790-000Osteopathic Solution Segmentsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥848m |
| jpcrp040300-q2r_E33790-000Osteopathic Solution Segmentsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥333m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | −¥356m |
| jpcrp040300-q2r_E33790-000Financial Services Segmentsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥490m |
| jpcrp040300-q2r_E33790-000Financial Services Segmentsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥490m |
| jpcrp040300-q2r_E33790-000Financial Services Segmentsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥29m |
| jpcrp040300-q2r_E33790-000Osteopathic Solution Segmentsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E33790-000Osteopathic Solution Segmentsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E33790-000Osteopathic Solution Segmentsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥70m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.7bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥98m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 512
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | 9768000 | JPY |
| Increase decrease in accrued expenses ope cf | Prior1YTDDuration | 8635000 | JPY |
| Increase decrease in accrued expenses ope cf | CurrentYTDDuration | 7587000 | JPY |
| Increase decrease in contract liabilities | Prior1YTDDuration | -3552000 | JPY |
| Increase decrease in contract liabilities | CurrentYTDDuration | 16779000 | JPY |
| Increase decrease in deposits received ope cf | Prior1YTDDuration | 84326000 | JPY |
| Increase decrease in deposits received ope cf | CurrentYTDDuration | 134861000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YTDDuration | 6405000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYTDDuration | -36033000 | JPY |
| Other net ope cf | Prior1YTDDuration | -69941000 | JPY |
| Other net ope cf | CurrentYTDDuration | -11688000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 45144000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -168637000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 7000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 11000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -5196000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -7288000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -48453000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -6172000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | -8497000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -182087000 | JPY |
| Payments into time deposits inv cf | Prior1YTDDuration | -2760000 | JPY |
| Payments into time deposits inv cf | CurrentYTDDuration | -2660000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | Prior1YTDDuration | 1300000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYTDDuration | 1200000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -24425000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -51035000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -164302000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -43030000 | JPY |
| Purchase of absorption type split | Prior1YTDDuration | － | JPY |
| Purchase of absorption type split | CurrentYTDDuration | -447746000 | JPY |
| Other net inv cf | Prior1YTDDuration | -196000 | JPY |
| Other net inv cf | CurrentYTDDuration | -9082000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -190384000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -552354000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 506000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 600000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -221938000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -300980000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | － | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -39491000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YTDDuration | 12808000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYTDDuration | － | JPY |
| Other net fin cf | Prior1YTDDuration | -110000 | JPY |
| Other net fin cf | CurrentYTDDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -209240000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 765528000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -408122000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |